Die WHO startet die Prüfung von drei potenziellen Covid-19-Medikamenten. (Symbolbild) 
Hauke-Christian Dittrich / dpa / picturedesk.com
Download von www.picturedesk.com am 11.05.2021 (19:46). 21 April 2021, Lower Saxony, Brunswick: Katharina Kleilein, a research assistant at Corat Therapeutics, checks selected antibodies with a pipette in a sterile area. The biotechnology company, founded in 2020 and based in Braunschweig, is developing a drug against Covid-19. Photo: Hauke-Christian Dittrich/dpa - 20210421_PD17676 - Rechteinfo: Rights Managed (RM)